The US-based Abbott Laboratories announced today that it has reopened its infant milk plant in Sturgis, Michigan a step toward alleviating the country's acute infant milk shortage.
The company said it will begin production of EleCare hypoallergenic milk and other infant milks andavailability will begin around June 20.
The U.S. Food and Drug Administration (FDA) had announced on May 19 that the plant could open within a week or two.
The facility now meets the requirements agreed with the FDA under the agreement Abbott entered into with the federal agency on May 16, the company said.
Recalled products in February
The plant's closure and recall of infant formula exacerbated the shortage in a country where, according to federal data by 2020, fewer than half of babies are exclusively fed breast milk for the first three months of their lives.
Abbott had begun recalling its products in February, following reports of bacterial infections in children who had consumed infant milk made at the plant.
[/P][BR][BR]An FDA inspection of the Sturgis facility had "shocking" results, finding cracks in vital equipment as well as serious hygiene problems.
The FDA subsequently agreed with Abbott to oversee the company's actions to correct the plant's problems.
Source: APE-MPA
Contents of this article including associated images are belongs Cyprus Times
Views & opinions expressed are those of the author and/or Cyprus Times
Source
